115 related articles for article (PubMed ID: 18802016)
1. Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling.
González-Navarro H; Vinué A; Vila-Caballer M; Fortuño A; Beloqui O; Zalba G; Burks D; Díez J; Andrés V
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2187-94. PubMed ID: 18802016
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
3. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/Lymphotoxin β-Receptor pathway.
Andrés-Blasco I; Vinué Á; Herrero-Cervera A; Martínez-Hervás S; Nuñez L; Piqueras L; Ascaso JF; Sanz MJ; Burks DJ; González-Navarro H
Thromb Haemost; 2016 Aug; 116(2):379-93. PubMed ID: 27172975
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice.
Gonzalez-Navarro H; Vila-Caballer M; Pastor MF; Vinue A; White MF; Burks D; Andres V
Front Biosci; 2007 Jan; 12():2291-8. PubMed ID: 17127239
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
6. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
7. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes.
Collins AR; Lyon CJ; Xia X; Liu JZ; Tangirala RK; Yin F; Boyadjian R; Bikineyeva A; Praticò D; Harrison DG; Hsueh WA
Circ Res; 2009 Mar; 104(6):e42-54. PubMed ID: 19265038
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
9. The IRS2 Gly1057Asp variant is associated with human longevity.
Barbieri M; Rizzo MR; Papa M; Boccardi V; Esposito A; White MF; Paolisso G
J Gerontol A Biol Sci Med Sci; 2010 Mar; 65(3):282-6. PubMed ID: 19887537
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice.
Scott NJ; Cameron VA; Raudsepp S; Lewis LK; Simpson ER; Richards AM; Ellmers LJ
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E576-84. PubMed ID: 22185842
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
[TBL] [Abstract][Full Text] [Related]
13. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
Harb D; Bujold K; Febbraio M; Sirois MG; Ong H; Marleau S
Cardiovasc Res; 2009 Jul; 83(1):42-51. PubMed ID: 19264766
[TBL] [Abstract][Full Text] [Related]
14. Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1.
Galkina EV; Butcher M; Keller SR; Goff M; Bruce A; Pei H; Sarembock IJ; Sanders JM; Nagelin MH; Srinivasan S; Kulkarni RN; Hedrick CC; Lattanzio FA; Dobrian AD; Nadler JL; Ley K
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):247-56. PubMed ID: 22199371
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
Clough MH; Schneider DJ; Sobel BE; White MF; Wadsworth MP; Taatjes DJ
J Histochem Cytochem; 2005 May; 53(5):603-10. PubMed ID: 15872053
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistance.
Perez-Martinez P; Delgado-Lista J; Garcia-Rios A; Tierney AC; Gulseth HL; Williams CM; Karlström B; Kieć-Wilk B; Blaak EE; Helal O; Saris WH; Defoort C; Drevon CA; Lovegrove JA; Dembinska-Kieć A; Riserus U; Roche HM; Lopez-Miranda J
Mol Nutr Food Res; 2012 Feb; 56(2):309-15. PubMed ID: 22147666
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
18. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
[TBL] [Abstract][Full Text] [Related]
19. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
[TBL] [Abstract][Full Text] [Related]
20. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet.
Pejnovic N; Vratimos A; Lee SH; Popadic D; Takeda K; Akira S; Chan WL
Mol Immunol; 2009 Nov; 47(1):37-45. PubMed ID: 19201478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
